Jefferies cuts Alnylam Pharmaceuticals target price to $180 from $250
ALNY•Jefferies cut its target price for Alnylam Pharmaceuticals to $180 from $250.
Related News
KBW raises Bankwell Financial Group target price to $79 from $72
BWFG•
KBW raises Mastercard target price to $750 from $685
MA•
Tenet Healthcare target price raised to $325 from $300
THC•
Roblox Corporation: Jefferies cuts target price to $35 from $38
RBLX•
Arthur J. Gallagher & Co.: KBW raises target price to $275 from $242
AJG•